AU2003900887A0 - Poloxamer emulsion preparations - Google Patents

Poloxamer emulsion preparations

Info

Publication number
AU2003900887A0
AU2003900887A0 AU2003900887A AU2003900887A AU2003900887A0 AU 2003900887 A0 AU2003900887 A0 AU 2003900887A0 AU 2003900887 A AU2003900887 A AU 2003900887A AU 2003900887 A AU2003900887 A AU 2003900887A AU 2003900887 A0 AU2003900887 A0 AU 2003900887A0
Authority
AU
Australia
Prior art keywords
poloxamer
emulsion preparations
preparations
emulsion
poloxamer emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003900887A
Inventor
Steen B. Jorsal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novasel Australia Pty Ltd
Original Assignee
Novasel Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasel Australia Pty Ltd filed Critical Novasel Australia Pty Ltd
Priority to AU2003900887A priority Critical patent/AU2003900887A0/en
Publication of AU2003900887A0 publication Critical patent/AU2003900887A0/en
Priority to CA2516863A priority patent/CA2516863C/en
Priority to PCT/AU2004/000218 priority patent/WO2004076561A1/en
Priority to EA200501368A priority patent/EA017434B1/en
Priority to EP04712958A priority patent/EP1597318A4/en
Priority to BRPI0408056-4A priority patent/BRPI0408056A/en
Priority to AU2004215921A priority patent/AU2004215921A1/en
Priority to JP2006501371A priority patent/JP2006519272A/en
Priority to CN200480005486A priority patent/CN100591721C/en
Priority to US11/085,646 priority patent/US8802116B2/en
Priority to NO20054395A priority patent/NO20054395L/en
Priority to AU2009202265A priority patent/AU2009202265B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003900887A 2003-02-27 2003-02-27 Poloxamer emulsion preparations Abandoned AU2003900887A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AU2003900887A AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations
CN200480005486A CN100591721C (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
EP04712958A EP1597318A4 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
PCT/AU2004/000218 WO2004076561A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
EA200501368A EA017434B1 (en) 2003-02-27 2004-02-20 Stable local and/or mucosal emulsion preparations (embodiments), method for preparing (embodiments) and use thereof (embodiments)
CA2516863A CA2516863C (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
BRPI0408056-4A BRPI0408056A (en) 2003-02-27 2004-02-20 an emulsion composition, a method for preparing an emulsion composition, use of an emulsion composition
AU2004215921A AU2004215921A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
JP2006501371A JP2006519272A (en) 2003-02-27 2004-02-20 Poloxamer emulsion formulation
US11/085,646 US8802116B2 (en) 2003-02-27 2005-03-21 Poloxamer emulsion preparations
NO20054395A NO20054395L (en) 2003-02-27 2005-09-22 Poloxamer emulsion preparations
AU2009202265A AU2009202265B2 (en) 2003-02-27 2009-06-09 Poloxamer Emulsion Preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003900887A AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations

Publications (1)

Publication Number Publication Date
AU2003900887A0 true AU2003900887A0 (en) 2003-03-13

Family

ID=31499933

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2003900887A Abandoned AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations
AU2004215921A Abandoned AU2004215921A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
AU2009202265A Ceased AU2009202265B2 (en) 2003-02-27 2009-06-09 Poloxamer Emulsion Preparations

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2004215921A Abandoned AU2004215921A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations
AU2009202265A Ceased AU2009202265B2 (en) 2003-02-27 2009-06-09 Poloxamer Emulsion Preparations

Country Status (9)

Country Link
EP (1) EP1597318A4 (en)
JP (1) JP2006519272A (en)
CN (1) CN100591721C (en)
AU (3) AU2003900887A0 (en)
BR (1) BRPI0408056A (en)
CA (1) CA2516863C (en)
EA (1) EA017434B1 (en)
NO (1) NO20054395L (en)
WO (1) WO2004076561A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102014957B (en) * 2008-04-21 2014-12-10 奥德纳米有限公司 Auris formulations for treating otic diseases and conditions
WO2010076730A1 (en) * 2009-01-02 2010-07-08 Donald, Jenny Method for the treatment of an hiv infection
MY163215A (en) * 2010-04-01 2017-08-30 Pharmanest Ab Thermogelling anaesthetic compositions
EP2689774B1 (en) 2011-03-21 2019-01-30 Broda Technologies Co., Ltd Reversely thermo-reversible hydrogel compositions
ITMI20131927A1 (en) 2013-11-20 2015-05-21 Cosmo Technologies Ltd EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION. EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTION AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION
SI3122799T1 (en) * 2014-03-25 2020-06-30 F. Hoffmann-La Roche Ag Methods of preparing a poloxamer for use in cell culture medium
US10351750B2 (en) 2017-02-03 2019-07-16 Saudi Arabian Oil Company Drilling fluid compositions with enhanced rheology and methods of using same
KR101852718B1 (en) * 2017-04-04 2018-05-18 주식회사 제네웰 Kit for pain reduction of incision site after surgical operation
WO2019125783A1 (en) * 2017-12-21 2019-06-27 Sigma-Aldrich Co. Llc Poloxamer compositions and methods of making and using same
IT201900018752A1 (en) * 2019-10-14 2021-04-14 Alessandro Tosetti COMPOSITION BASED ON ESSENTIAL OILS FOR DENTAL USE FOR THE TREATMENT OF PERIODONTITIS AND PERIMPLANT MUCOSITE
RU2762506C1 (en) * 2021-01-20 2021-12-21 Общество С Ограниченной Ответственностью «Диамед-Фарма» Agent for applying oral and nasal cavities and method for its use as part of complex therapy of infectious and inflammatory diseases of nasal and oral cavities
CN114455621B (en) * 2022-01-11 2023-10-27 兰州交通大学 Preparation method of needle-shaped calcium carbonate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4312489A (en) * 1988-09-23 1990-04-18 Cetus Corporation Lipid microemulsions for culture media
JPH0791555B2 (en) * 1989-12-22 1995-10-04 株式会社資生堂 Cleaning composition
JP4157969B2 (en) * 1994-03-18 2008-10-01 スパーナス ファーマシューティカルズ インコーポレイテッド Emulsified drug delivery system
ES2094688B1 (en) * 1994-08-08 1997-08-01 Cusi Lab MANOEMULSION OF THE TYPE OF OIL IN WATER, USEFUL AS AN OPHTHALMIC VEHICLE AND PROCEDURE FOR ITS PREPARATION.
SE9601421D0 (en) * 1996-04-12 1996-04-12 Astra Ab New composition
DE19723308A1 (en) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Microemulsions useful for topical administration of e.g. local anaesthetics
FR2788007B1 (en) * 1999-01-05 2001-02-09 Oreal NANOEMULSION BASED ON BLOCK COPOLYMERS OF ETHYLENE OXIDE AND PROPYLENE OXIDE, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
WO2000051550A1 (en) * 1999-03-01 2000-09-08 Basf Corporation Cold processed water-in-oil emulsions
CA2377614C (en) * 1999-06-21 2008-07-29 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
SE0000774D0 (en) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs

Also Published As

Publication number Publication date
WO2004076561A1 (en) 2004-09-10
CA2516863C (en) 2011-12-06
CN100591721C (en) 2010-02-24
EP1597318A4 (en) 2006-06-14
AU2004215921A1 (en) 2004-09-10
EP1597318A1 (en) 2005-11-23
JP2006519272A (en) 2006-08-24
EA200501368A1 (en) 2006-02-24
AU2009202265B2 (en) 2012-02-16
CN1753949A (en) 2006-03-29
NO20054395L (en) 2005-09-22
EA017434B1 (en) 2012-12-28
BRPI0408056A (en) 2006-02-14
CA2516863A1 (en) 2004-09-10
AU2009202265A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
AU2003298738A1 (en) Liposomal formulations
AU2003273000A1 (en) Stable solid preparations
IL173808A0 (en) Pharmaceutical liposomal formulations
HK1079099A1 (en) Quickly soluble film preparations
AU2003224121A1 (en) Pigment preparations
EP1831240B8 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
AU2003242239A1 (en) Cosmetic preparation
AU2002257582A1 (en) Pharmaceutical formulation
AU2003304507A1 (en) Anti-coronavirus agent
AU2003255398A1 (en) Lipid preparation, particularly cosmetic preparation
AU2003213345A1 (en) Cosmetic preparation
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003900887A0 (en) Poloxamer emulsion preparations
AU2003226487A1 (en) Formulation
AU2003285320A1 (en) Vaccine
AU2003229199A1 (en) Liposome vaccine formulations for fin-fish
AU2003227209A1 (en) Processor
AU2003213146A1 (en) Activated protein c formulations
AU2002352153A1 (en) Instant emulsion
AU2003268787A1 (en) Emulsifier
AU2003289718A1 (en) Cosmetic preparation
GB0308691D0 (en) Vaccine preparations
AU2003900767A0 (en) Idiotypic vaccine
AU2003293936A1 (en) Oil-acid emulsion and use thereof
EP1642586A4 (en) Cell-containing preparations